Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
CRYAB-650 C>G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Therapeutic strategies targeting B-cells in multiple sclerosis.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Therapies for multiple sclerosis: translational achievements and outstanding needs.
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.]
The Outlook for Alemtuzumab in Multiple Sclerosis.
Ipilimumab in patients with melanoma and autoimmune disease.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis].
Neuroinflammation: The Devil is in the Details.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Immunity and inflammation in neurodegenerative diseases.
Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Early detection of thrombin activity in neuroinflammatory disease.
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis.
Pages
« first
‹ previous
…
578
579
580
581
582
583
584
585
586
…
next ›
last »